drugset / Trial / NCT03405090

Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators

NCT03405090

RandomizedCrossoverDouble-blindTreatment

Summary

Activity-related breathlessness (dyspnea) is the dominant symptom and persists despite optimal medical care in as many as 50% of patients with advanced chronic obstructive pulmonary disease (COPD). The objective of this project is to determine the underlying mechanisms of the activity-related breathlessness in patients with advanced COPD. To study the different pathways involved in causing breathlessness, we will compare the effects of two treatments, opiates with oxygen versus bronchodilators, which relieve breathlessness in different ways.

Timeline

Start
2017-09-20
Primary completion
2022-03-21
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 100 ug Inhaled
Comparator Ipratropium Small molecule 0.5 mg Inhaled
Comparator Salbutamol Unknown 2.5 mg Inhaled